Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rifaximin DR by Bausch Health for Sickle Cell Disease: Likelihood of Approval
Rifaximin DR is under clinical development by Bausch Health and currently in Phase II for Sickle Cell Disease. According to...